The present invention relates generally to apparatus and methods for sealing punctures in a body, and more particularly, to apparatus and methods for sealing a vascular puncture extending through tissue into a blood vessel, and to apparatus and methods for delivering a plug, sealant, and/or other material into a percutaneous puncture extending from a patient's skin to a blood vessel or other body lumen, e.g., to seal the puncture.
Apparatus and methods are known for accessing a patient's vasculature percutaneously, e.g., to perform a procedure within the vasculature, and for sealing the puncture that results after completing the procedure. For example, a hollow needle may be inserted through a patient's skin and overlying tissue into a blood vessel. A guide wire may be passed through the needle lumen into the blood vessel, whereupon the needle may be removed. An introducer sheath may then be advanced over the guide wire into the vessel, e.g., in conjunction with or subsequent to one or more dilators.
A catheter or other device may be advanced through the introducer sheath and over the guide wire into a position for performing a medical procedure. Thus, the introducer sheath may facilitate accessing and/or introducing various devices into the vessel, while minimizing trauma to the vessel wall and/or minimizing blood loss. Upon completing the procedure, the device(s) and introducer sheath may be removed, leaving a puncture extending between the skin and the vessel wall.
To seal the puncture, external pressure may be applied to the overlying tissue, e.g., manually and/or using sandbags, until hemostasis occurs. This procedure, however, may be time consuming and expensive, requiring as much as an hour of a medical professional's time. It is also uncomfortable for the patient, and may require the patient to remain immobilized in the operating room, catheter lab, or holding area. In addition, a risk of hematoma exists from bleeding before hemostasis occurs.
Various apparatus and methods have been suggested for sealing a percutaneous puncture instead of using external pressure. For example, U.S. Pat. No. 5,108,421 to Fowler discloses a plug that may be delivered into a puncture through tissue. U.S. Pat. Nos. 5,192,302 and 5,222,974 issued to Kensey et al. describe a bioabsorbable collagen plug that may be delivered through an introducer sheath into a puncture site. The disclosed plug, however, may be difficult to position properly with respect to the vessel, which may be significant since it is generally undesirable to expose the collagen material within the bloodstream where it may float downstream and cause an embolism.
U.S. Pat. No. 6,605,294 describes rods, plugs, and crushed or irregularly shaped pieces of substantially dehydrated hydrogel that may be introduced into a lumen or void in a patient's body, e.g., to seal or plug a biopsy needle track, reinforce weak tissue, or deliver a therapeutic compound. In one embodiment, a plug of dehydrated hydrogel may be deployed into the site of an arteriotomy and allowed to hydrate in the presence of the tissue fluids and blood, to fill the tract of the catheter sheath and prevent further bleeding. By swelling to equilibrium hydration, the plug may lock itself firmly in place and thus reduce the risk of formation of a large hematoma at the site of the puncture.
U.S. Pat. No. 6,703,047 discloses dehydrated hydrogel precursor-based, tissue adherent compositions. The hydrogels may be used, for example, for sealing fluid leaks from tissue, as adherent drug delivery depots, and as means for augmenting and/or supporting tissue. The hydrogels may be administered directly to an open wound site or may be dispensed, e.g., using a non-adhesive backing material, an absorbable backing material, a syringe applicator, a powder atomization or aerosolization system, or a needle-less injector.
The present invention is directed to apparatus and methods for sealing a puncture in a body, and, more particularly, to apparatus and methods for providing temporary or permanent hemostasis within a vascular puncture extending into a blood vessel, and/or to apparatus and methods for delivering a sealant and/or other material into a percutaneous puncture extending from a patient's skin to a blood vessel or other body lumen.
In accordance with one embodiment, an apparatus is provided for sealing a puncture extending through tissue having an introducer sheath therein that includes a proximal end including a hub, a distal end, and a lumen extending therebetween. The apparatus includes an elongate positioning member including a housing on a proximal end thereof, and an expandable positioning element on a distal end thereof, and a cartridge advanceable along the positioning member from a proximal position adjacent the housing to a distal position. The cartridge may include a tubular member, a sealant disposed within a lumen of the tubular member, e.g., adjacent the tubular member distal end, and an advancer member disposed within the tubular member lumen adjacent the sealant, e.g., for exposing the sealant from the tubular member lumen when the tubular member is retracted proximally relative to the advancer member.
In addition, the cartridge includes a sleeve slidably disposed over the tubular member distal end, e.g., covering a slitted distal tip of the tubular member. Optionally, the sleeve may include an inner surface configured to provide preferential or different frictional interference with an outer surface of the tubular member, e.g., to allow proximal movement and resist distal movement of the sleeve over the tubular member. At least a portion of the sleeve may be sized to abut the introducer sheath hub such that, when the tubular member is advanced from the proximal position to the distal position, the tubular member distal end enters the introducer sheath lumen while the sleeve is stopped by the introducer sheath hub and slides over the tubular member to expose the tubular member distal end within the introducer sheath lumen.
For example, in one embodiment, the sleeve may include a distal portion sized to enter the introducer sheath hub when the cartridge is advanced towards the distal position and a proximal portion that abuts the introducer sheath hub to prevent the entire sleeve from entering the introducer sheath lumen. The introducer sheath hub may include a valve therein, and the sleeve distal portion may at least partially open the valve when the cartridge is advanced towards the distal position, e.g., to facilitate the tubular member distal end entering the introducer sheath lumen.
Optionally, the positioning member and/or cartridge may include one or more features that limit distal movement of the tubular member when the cartridge is advanced from the proximal position to the distal position. For example, features may be provided on the positioning member to prevent further distal movement of the tubular member when the tubular member distal end is spaced a predetermined distance from the positioning element.
In accordance with another embodiment, a system is provided for sealing a puncture through tissue that generally includes an introducer sheath, a positioning member, and a cartridge. The introducer sheath may include a proximal end including a hub, a distal end sized for introduction into a puncture, and a lumen extending therebetween. The positioning member may include an elongate member including a housing on a proximal end thereof and an expandable positioning element on a distal end thereof. The cartridge may be advanceable along the positioning member from a proximal position to a distal position, and may include a tubular member including a sealant and an advancer member disposed within lumen of the tubular member. A sleeve is slidably disposed over the tubular member distal end such that, when the tubular member is advanced over the positioning member after introducing the positioning element through the introducer sheath, the tubular member distal end enters the introducer sheath lumen while the sleeve is stopped by the introducer sheath hub and slides over the tubular member to expose the tubular member distal end within the introducer sheath lumen.
In accordance with still another embodiment, a method is provided for sealing a puncture extending through tissue to a body lumen, the puncture having an introducer sheath therein. An apparatus may be provided including an elongate positioning member including proximal and distal ends, a cartridge slidable on the positioning member and carrying a sealant therein, and a slidable sleeve located over a distal end of the cartridge.
The distal end of the positioning member may be introduced through a lumen of the introducer sheath until a positioning element thereon is disposed within the body lumen. Optionally, the positioning element may be expanded within the body lumen, and the positioning member may be refracted until the expanded positioning element contacts a wall of the body lumen.
The cartridge may be advanced over the positioning member, e.g., until the sleeve on the cartridge contacts a proximal end of the introducer sheath. The cartridge may be advanced further, e.g., as one substantially continuous movement, such that the cartridge distal end enters the introducer sheath lumen while the sleeve is stopped by the introducer sheath. During this further advancement, the sleeve may slide over the cartridge to expose the cartridge distal end within the introducer sheath lumen, e.g., until a distal position is attained.
The introducer sheath and cartridge may then be at least partially retracted from the puncture, thereby exposing the sealant within the puncture distally beyond the introducer sheath. The expanded positioning element may then be collapsed, and the positioning member withdrawn from the puncture, e.g., leaving the sealant within the puncture. In one embodiment, the cartridge may include an advancer member adjacent the sealant that remains within the puncture when the introducer sheath and cartridge are retracted. In this embodiment, the positioning member may be withdrawn through the sealant and advancer member. For example, the advancer member may be held substantially stationary while the positioning member is withdrawn from the puncture to prevent substantial proximal movement of the sealant. In addition or alternatively, the advancer member may be advanced to compress the sealant within the puncture, e.g., before or after withdrawing the positioning member. The advancer member may then be withdrawn, leaving the sealant within the puncture.
Other aspects and features of the present invention will become apparent from consideration of the following description taken in conjunction with the accompanying drawings.
It will be appreciated that the exemplary apparatus shown in the drawings are not necessarily drawn to scale, with emphasis instead being placed on illustrating the various aspects and features of the illustrated embodiments.
Turning to the drawings,
As best seen in
As shown in
In addition, the slits 27 may accommodate slight expansion of the sealant 2 before being exposed from the tubular member 20. For example, a distal surface of the sealant 2 may be exposed to bodily fluids when the cartridge 16 is advanced into a puncture, which may hydrate and cause the distal end of the sealant 2 to expand slightly. Optionally, the distal end 24 of the tubular member 20 may be exposed to water or other fluid before use of the apparatus 10, e.g., to partially hydrate the distal end of the sealant 2 and cause the distal end to expand slightly. The slits 27 may allow the distal end 24 of the tubular member 20 to open to accommodate such expansion. Otherwise, if the sealant 2 hydrates and/or otherwise expands within the tubular member 20, the sealant 2 may impose radially outward forces, which may hinder retracting the tubular member 20 to expose the sealant 2.
In the exemplary embodiment shown, a single longitudinal slit 27 is cut or otherwise formed on one side of the distal tip 25 that extends proximally from the distal tip 25, e.g., about ten to twenty millimeters (10-20 mm). Alternatively, a pair of slits may be provided, e.g., on opposite sides of the distal tip 25 or more than two slits may be provided, if desired (not shown). The length of the slit(s) may be less than, substantially equal to, or longer than the length of the sealant 2, e.g., to reduce the risk of jamming if the sealant 2 begins to expand within the distal tip 25, as described elsewhere herein.
A slit that is longer than the sealant 2 may provide hydraulic benefits, e.g., when the cartridge 16 is advanced to introduce the sealant 2 into a puncture. For example, during use, as the cartridge 16 is advanced into an introducer sheath (not shown), as described further below, fluid inside the introducer sheath may be displaced distally by the cartridge 16, which may increase pressure at the distal end 24 of the tubular member 20 and/or introducer sheath. This increased hydraulic pressure at the distal end 24 of the tubular member 20 may also transmit along the sides of the cartridge 16, e.g., if there is a gap between the inner diameter of the introducer sheath and the outer diameter of the tubular member 20. A longer slit 27 may allow some relief of this pressure, e.g., by blood or other fluid within the introducer sheath flowing in directly behind the sealant 2 within the lumen 26 of the tubular member 20 and/or otherwise within the cartridge 16. Such infusion behind the sealant 2 may also have the benefit of pre-hydrating the sealant 2, which may enhance the ability of the sealant 2 to expand quickly when deployed within a puncture or otherwise within the patient's body.
With further reference to
The advancer member 30 may be substantially rigid, semi-rigid, and/or substantially flexible, having sufficient column strength to allow proximal movement of the tubular member 20 relative to the sealant 2 without buckling the advancer member 30 and/or to allow the distal end 34 of the advancer member 30 to be advanced to compress the sealant 2 within a puncture, e.g., by pushing from the proximal end 32, as described further below. The advancer member 30 may also include a lumen 36 extending between the proximal and distal ends 32, 34, e.g., to accommodate the positioning member 14, a guidewire, a flowable sealing compound, and/or fluid (not shown).
Optionally, the advancer member 30 may include one or more elements (not shown) on the proximal end 32, e.g., for interacting with one or more cooperating elements (also not shown) on the positioning member 14, e.g., to limit movement of the advancer member 30 relative to the positioning member 14. For example, the element(s) may simply be a relatively narrow region (not shown) on the proximal end 32. Alternatively, the element(s) may be a separate collar or sleeve, one or more inwardly oriented detents, and the like (also not shown) attached to or otherwise formed on the proximal end 32 of the advancer member 30.
The sealant 2 may be disposed within the lumen 26 of the tubular member 20 proximate to the distal end 24, e.g., immediately adjacent the distal tip 25, as shown in
The sealant 2 may include a biocompatible, bioabsorbable, and/or expandable material, such as a freeze-dried hydrogel. The sealant 2 may have a solid or hollow cylindrical shape, a rolled sheet shape, a disk shape, or other shapes or cross-sections, such as elliptical, triangular, square, conical, disk, polygonic shapes. For example, the sealant 2 may be formed from a solid material including a lumen (not shown) extending between proximal and distal ends thereof. The lumen may be created by rolling a sheet of material around a mandrel, by molding, by boring into or otherwise removing material from an already formed solid material, and the like. The lumen may be dimensioned such that the positioning member 14, a guidewire or other instrument (not shown) may slide or otherwise pass through the sealant 2, as described elsewhere herein.
In one embodiment, the sealant 2 may be formed from a biocompatible and/or bioabsorbable hydrogel, e.g., polyethylene glycol (“PEG”), or other synthetic material. For example, the hydrogel may include a lyophilized (i.e., freeze-dried) PEG polymer that includes hydrolytically degradable chemical groups, e.g., including a macroporous polymer network, which may uptake fluid and expand when exposed to an aqueous environment. The magnitude of expansion or swelling (pre to post hydration) may be significant, e.g., between about two and ten times (2×-10×) its lyophilized size based on volume.
In addition or alternatively, the sealant 2 may include pro-thrombotic material, e.g., including one or more biological pro-thrombotics, such as collagen, fibrin, carboxymethylcellulose, oxidized cellulose, alginates, gelatin, or other protein-based material, and/or synthetic materials, such as polyglycolic acids (PGA's), polyactides (PLA's), polyvinyl alcohol, and the like.
Optionally, the sealant 2 may include one or more therapeutic and/or pharmaceutical agents, e.g., to promote healing, prevent infection and/or other adverse medical events, and the like. Such agents may be embedded in the sealant material and/or applied as one or more coatings or layers. In addition or alternatively, the sealant 2 may be substantially homogeneous, or may include one or more different materials at one or more locations. For example, in one embodiment, the sealant 2 may include a carrier or core having first and second hydrogel precursors disposed thereon in an unreactive state, which may provide an adherent coating when the sealant 2 is exposed to an aqueous environment.
Exemplary materials and methods for making and using them are disclosed in U.S. Pat. Nos. 6,152,943, 6,165,201, 6,179,862, 6,514,534, 6,379,373, 6,703,047, 7,790,192, and in co-pending application Ser. Nos. 10/010,715 filed Nov. 9, 2001, 10/068,807 filed Feb. 5, 2002, 10/454,362, filed Jun. 4, 2003, published as US 2004/0249342, 10/982,384, filed Nov. 5, 2004, published as US 2006/0099238, and 11/465,791, filed Aug. 18, 2006. The disclosures of these references are expressly incorporated by reference herein.
Additionally, as shown in
As best seen in
The sleeve 50 may have a relatively short length compared to the tubular member 20, e.g., such that the sleeve 50 may slide proximally over the tubular member 20 a desired distance. For example, the sleeve 50 may have an overall length between about twelve and twenty four millimeters (12-24 mm), and the distal portion 54 may have a length, e.g., between about three and twenty millimeters (3-20 mm).
Optionally, the sleeve 50 may include an inner lumen 56 configured to provide preferential and/or different frictional interference with an outer surface of the tubular member 20. For example, the inner lumen 56 may allow the sleeve 50 to slide freely proximally relative to the tubular member 20, while providing enhanced friction that resists distal movement of the sleeve 50 over the tubular member 20. In addition or alternatively, the sleeve 50 may be releasably attached to the cartridge 16, e.g., using a low bond adhesive, and the like, which may be released or otherwise overcome when the cartridge 16 is advanced into an introducer sheath, as described further below.
In an exemplary embodiment, shown in
As best seen in
Returning to
For example, as shown, the positioning element may be a balloon 46, and the positioning member 14 may include a tubular body 40 including a lumen (not shown) extending between the proximal and distal ends 42, 44 and communicating with an interior of the balloon 46. In this embodiment, the positioning member 14 may include a source of inflation media, e.g., a syringe (not shown), that may be coupled to a housing 48 on the proximal end 142 of the positioning member 14. Optionally, the positioning member 14 may include an internal pull wire (not shown) that causes the balloon 46 to shorten during expansion and extend during collapse. Exemplary embodiments of positioning members 14 including balloons that may be used are disclosed in co-pending applications Ser. No. 10/454,362, filed Jun. 4, 2003, published as US 2004/0249342, Ser. No. 11/112,877, filed Apr. 22, 2005, published as US 2006/0253072, and Ser. No. 11/112,971, filed Apr. 22, 2005, and published international application WO 2006/115904. The entire disclosures of these references are expressly incorporated by reference herein.
Alternatively, the positioning element may be biased to an enlarged condition, but may be compressed to a contracted condition, e.g., by an overlying sleeve or other constraint (not shown). The constraint may be removed to expose the positioning element, allowing the expandable element to automatically expand to the enlarged condition. Additional information on expandable structures that may be provided on the positioning member 14 may be found in U.S. Pat. Nos. 6,238,412, 6,635,068, and 6,890,343, and in co-pending application Ser. No. 10/975,205, filed Oct. 27, 2004. The entire disclosures of these references are expressly incorporated herein by reference.
Turning to
As shown in
Optionally, the cartridge 16 and/or positioning member 14 may include cooperating features that limit distal movement of the cartridge 16 relative to the positioning member 14. For example, as shown in
The detent 41a may be provided on the outer surface of the elongate member 40 at a predetermined location between the proximal and distal ends 42, 44 such that the distal end 24 of the tubular member 20 is spaced apart from the positioning element 46 by a predetermined distance, e.g., providing between about two and five millimeters (2-5 mm) clearance between the distal end 24 and the positioning element 46. Alternatively, the detent 41a may be provided at a predetermined location such that the distal end 24 of the tubular member may be jammed or otherwise extend into the positioning element 46, e.g., by zero to two millimeters (0-2 mm).
The detent 41a may be a raised feature formed or attached to the elongate member 40 at the predetermined location. For example, the detent may be a proximal end of a section of tubing, e.g., heat shrink tubing, a collar, or other sleeve (not shown) attached around the elongate member 40, e.g., by bonding with adhesive, heat shrinking, ultrasonic welding, fusing, crimping, and the like. Alternatively, as shown, the detent 41a may overmolded or otherwise formed directly on the elongate member 40, as desired.
In addition or alternatively, the positioning member 14 and/or advancer member 30 may include one or more elements that engage when the cartridge 16 reaches a predetermined location when advanced along the positioning member 14, e.g., to limit subsequent proximal movement of the advancer member 30 relative to the positioning member 14 when the tubular member 20 is subsequently retracted. For example, the positioning member 14 may include a reduced diameter region (not shown) at a predetermined location, e.g., by providing a larger tube around a smaller inner tube or by machining, etching, or otherwise removing a portion of the tubular body of the positioning member 14 distal to the reduced region. The larger tube may extend from the proximal end of the positioning member 14 to the desired location for the detent, or may simply be a relatively short sleeve or other member (not shown) attached around or to the positioning member 14 at the desired location, e.g., to provide a first ratchet or detent that the advancer member 30 may pass over freely in the distal direction but not subsequently move proximally.
The advancer member 30 may include a living hinge, tab, or other element 37 (also not shown) on the proximal end 32 that may pass freely over the reduced regions, ratchets, and/or other detents on the positioning member 14, yet may be unable to pass proximally back over the reduced region. For example, as shown in
The first detent 41a may be provided at a predetermined location on the positioning member 14, e.g., a predetermined distance from the positioning element 46 that substantially corresponds to a length of the advancer member 30. As the cartridge 16 (and consequently the advancer member 30) is advanced over the positioning member 14, e.g., until the sealant 2 is disposed adjacent the positioning element 46, the element 37 on the advancer member 30 may pass freely over the first detent 41a, as best seen in
In addition or alternatively, one or more markers may be provided on the apparatus 10, e.g., to identify when components are located at one or more desired positions or otherwise to facilitate use of the apparatus 10. For example, as shown in
In addition or alternatively, as shown in
As best seen in
The introducer sheath 80 may be formed using known materials and/or methods, e.g., plastic with the tubular body and hub 83 substantially permanently connected together, e.g., using an interference fit, one or more mating connectors (not shown), bonding with adhesive, ultrasonic welding, and the like. The hub 83 generally includes one or more seals, e.g., one or more hemostatic seals (not shown) therein, which may prevent flow of blood or other fluids out of the hub 83 from the lumen 86, yet accommodate insertion of one or more instruments into the lumen 26, such as the positioning member 14 and/or cartridge 16. Optionally, as shown, the hub 83 may include a side port 89 communicating with the lumen 86, e.g., for coupling a source of saline or other fluid (not shown) to the hub 83.
Turning to
In an exemplary method, the puncture 90 may be created using known procedures, e.g., using a needle, guidewire, one or more dilators, and the like (not shown). An introducer sheath 80 may be advanced through the puncture 90 into the vessel 94, e.g., over a guide wire placed through the puncture 90 into the vessel 94. The introducer sheath 80 may provide access into the vessel 92 for one or more instruments (not shown), e.g., to allow one or more diagnostic and/or interventional procedures to be performed via the vessel 94. Upon completing the procedure(s) via the vessel 94, any such instrument(s) may be removed from the puncture 90, leaving the introducer sheath 80 extending through the puncture 90 into the vessel 94.
With reference to
Still referring to
In an exemplary method, this may involve a two-step process (although it may be completed in a single substantially continuous action). First, with the positioning element 46 expanded within the vessel 94, the positioning member 14 may be withdrawn until the positioning element 46 contacts the distal end 84 of the introducer sheath 80, which may provide a first tactile feedback to the user (i.e., that the positioning element 46 has contacted the introducer sheath 80, e.g., based upon the increased weight and/or resistance to proximal movement). The positioning member 14 may be withdrawn further until the positioning element 46 contacts the wall of the vessel 94 and resists further withdrawal, thereby providing a second tactile feedback. The introducer sheath 80 may be pulled proximally by the positioning element 46 as the positioning member 14 is withdrawn, e.g., until the distal end 84 of the introducer sheath 80 is withdrawn from the vessel 94 into the puncture 90, as shown in
Proximal tension may be applied and/or maintained on the positioning member 14 to hold the positioning element 46 against the wall of the vessel 94, e.g., to seal the puncture 90 from the vessel 94 and/or prevent further removal of the positioning member 14. The proximal tension may be maintained manually or using a tensioner device (not shown) to provide temporary hemostasis, e.g., during the subsequent steps. Exemplary tension devices are disclosed in co-pending application Ser. No. 10/806,952, filed Mar. 22, 2004, the entire disclosure of which is expressly incorporated herein by reference.
Turning to
The cartridge 16 may be further advanced into the introducer sheath 80 toward the positioning element 46, whereupon the sleeve 50 may remain substantially stationary relative to the introducer sheath 80 and, consequently, slide proximally over the tubular member 20. Thus, the distal end 24 of the tubular member 20 may exit the distal portion 54 of the sleeve 50 and enter the introducer sheath lumen 86. Optionally, the distal portion 54 of the sleeve 50 may have sufficient length to at least partially open the valve(s) within the introducer sheath hub 83, e.g., to facilitate the distal end 24 of the tubular member 20 being advanced into the introducer sheath lumen 86. Thus, the sleeve 50 may protect the slitted distal tip 25 of the tubular member 20 until the distal tip 25 passes into the hub 83 and/or lumen 86 of the introducer sheath 80.
The cartridge 16 may be advanced until a component of the cartridge 16 encounters a stop on the positioning member 14, thereby preventing further advancement of the cartridge 16 and/or spacing the sealant 2 a predetermined distance from the positioning element 46, e.g., about zero to five millimeters (0-5 mm) from the positioning element 46 or zero to two millimeters (0-2 mm) into or beyond the positioning member 14. For example, as shown in
Thereafter, as shown in
As the tubular member 20 is retracted, the advancer member 30 may prevent substantial proximal movement of the sealant 2, thereby exposing the sealant 2 within the puncture 90, as shown in
When the sealant 2 is exposed within the puncture 90, the sealant 2 may be exposed to blood and/or other body fluids within the puncture 90. This exposure may cause the sealant 2 to absorb fluid and/or otherwise expand within the puncture 90, e.g., to provide hemostasis. If desired, once the sealant 2 is exposed within the puncture 90, the advancer member 30 may be advanced to compress or tamp the sealant 2, e.g., against the positioning element 46. Optionally, the advancer member 30 may include one or more markers 33, e.g., on or adjacent the proximal end 32, and the advancer member 30 may be advanced into the puncture 90 a desired distance, which may be confirmed by monitoring the markers 33. In addition or alternatively, as shown in
Once the sealant 2 has been exposed for sufficient time and/or tamped by the advancer member 30, the positioning element 46 may be collapsed, and the positioning member 14 withdrawn from the vessel 94 and puncture 90, e.g., pulling the collapsed positioning element 46 through the sealant 2 and advancer member 30. The advancer member 30 may be maintained substantially stationary during withdrawal of the positioning member 14, e.g., to prevent migration and/or dislodgment of the sealant 2 within the puncture 90. Once the positioning member 14 is completely removed, the advancer member 30 may be removed from the puncture 90, leaving the sealant 2 within the puncture 90.
Optionally, after removing the positioning member 14, liquid hydrogel or other sealing compound, or other material may be delivered into the puncture 90, e.g., above and/or around the sealant 2, to assist in achieving hemostasis. For example, such material may be delivered via the lumen 36 of the advancer member 30 and/or by introducing another delivery device (not shown) into the puncture 90, e.g., after removing the advancer member 30.
While the invention is susceptible to various modifications, and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents and alternatives falling within the scope of the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
2115492 | Kober | Apr 1938 | A |
2365039 | Andresen | Dec 1944 | A |
3765419 | Usher | Oct 1973 | A |
4002173 | Manning | Jan 1977 | A |
4260077 | Schroeder | Apr 1981 | A |
4327709 | Hanson et al. | May 1982 | A |
4362150 | Lombardi, Jr. et al. | Dec 1982 | A |
4472542 | Nambu | Sep 1984 | A |
4540404 | Wolvek | Sep 1985 | A |
4654137 | Vaughan | Mar 1987 | A |
4655211 | Sakamoto et al. | Apr 1987 | A |
4664857 | Nambu | May 1987 | A |
4734097 | Tanabe | Mar 1988 | A |
4738658 | Magro et al. | Apr 1988 | A |
4801434 | Kido et al. | Jan 1989 | A |
4838280 | Haaga | Jun 1989 | A |
4838864 | Peterson | Jun 1989 | A |
4852568 | Kensey | Aug 1989 | A |
4890612 | Kensey | Jan 1990 | A |
5061274 | Kensey | Oct 1991 | A |
5087246 | Smith | Feb 1992 | A |
5104375 | Wolf et al. | Apr 1992 | A |
5104389 | Deem et al. | Apr 1992 | A |
5108421 | Fowler | Apr 1992 | A |
5192300 | Fowler | Mar 1993 | A |
5192302 | Kensey et al. | Mar 1993 | A |
5221259 | Weldon et al. | Jun 1993 | A |
5222974 | Kensey et al. | Jun 1993 | A |
5258042 | Mehta | Nov 1993 | A |
5259835 | Clark et al. | Nov 1993 | A |
5275616 | Fowler | Jan 1994 | A |
5290310 | Makower et al. | Mar 1994 | A |
5292332 | Lee | Mar 1994 | A |
5306254 | Nash et al. | Apr 1994 | A |
5320639 | Rudnick | Jun 1994 | A |
5324306 | Makower et al. | Jun 1994 | A |
5334216 | Vidal | Aug 1994 | A |
5370660 | Weinstein | Dec 1994 | A |
5383896 | Gershony | Jan 1995 | A |
RE34866 | Kensey et al. | Feb 1995 | E |
5391183 | Janzen et al. | Feb 1995 | A |
5409703 | McAnalley | Apr 1995 | A |
5413571 | Katsaros et al. | May 1995 | A |
5419765 | Weldon et al. | May 1995 | A |
5431639 | Shaw | Jul 1995 | A |
5437292 | Kipshidze et al. | Aug 1995 | A |
5437631 | Janzen | Aug 1995 | A |
5441517 | Kensey et al. | Aug 1995 | A |
5443481 | Lee | Aug 1995 | A |
5464396 | Barta et al. | Nov 1995 | A |
5486195 | Myers et al. | Jan 1996 | A |
5489278 | Abrahamson | Feb 1996 | A |
5514158 | Kanesaka | May 1996 | A |
5529577 | Hammerslag | Jun 1996 | A |
5550187 | Rhee | Aug 1996 | A |
5571181 | Li | Nov 1996 | A |
5580923 | Yeung | Dec 1996 | A |
5584815 | Pawelka et al. | Dec 1996 | A |
5591204 | Janzen et al. | Jan 1997 | A |
5591205 | Fowler | Jan 1997 | A |
5601602 | Fowler | Feb 1997 | A |
5626601 | Gershony et al. | May 1997 | A |
5637086 | Ferguson | Jun 1997 | A |
5643464 | Rhee | Jul 1997 | A |
5660849 | Polson et al. | Aug 1997 | A |
5700477 | Rosenthal | Dec 1997 | A |
5716375 | Fowler | Feb 1998 | A |
5718916 | Scherr | Feb 1998 | A |
5725498 | Janzen | Mar 1998 | A |
5725551 | Myers et al. | Mar 1998 | A |
5728122 | Leschinsky et al. | Mar 1998 | A |
5728132 | Van Tassel et al. | Mar 1998 | A |
5731368 | Stanley et al. | Mar 1998 | A |
5741223 | Janzen et al. | Apr 1998 | A |
5744153 | Yewey et al. | Apr 1998 | A |
5752974 | Rhee et al. | May 1998 | A |
5780044 | Yewey et al. | Jul 1998 | A |
5782860 | Epstein et al. | Jul 1998 | A |
5785679 | Abolfathi et al. | Jul 1998 | A |
5795331 | Cragg et al. | Aug 1998 | A |
5814016 | Valley | Sep 1998 | A |
5830130 | Janzen et al. | Nov 1998 | A |
5836970 | Pandit | Nov 1998 | A |
5843124 | Hammerslag | Dec 1998 | A |
5868778 | Gershony | Feb 1999 | A |
5916236 | Muijs Van de Moer et al. | Jun 1999 | A |
5922009 | Epstein et al. | Jul 1999 | A |
5928266 | Kontos | Jul 1999 | A |
5941847 | Huber et al. | Aug 1999 | A |
5948429 | Bell | Sep 1999 | A |
5948829 | Wallajapet | Sep 1999 | A |
5951583 | Jensen et al. | Sep 1999 | A |
5951589 | Epstein et al. | Sep 1999 | A |
5957952 | Gershony | Sep 1999 | A |
5972375 | Truter | Oct 1999 | A |
5973014 | Funk | Oct 1999 | A |
6017359 | Gershony | Jan 2000 | A |
6022361 | Epstein et al. | Feb 2000 | A |
6027471 | Fallon et al. | Feb 2000 | A |
6045570 | Epstein et al. | Apr 2000 | A |
6048358 | Barak | Apr 2000 | A |
6051248 | Sawhney | Apr 2000 | A |
6056768 | Cates | May 2000 | A |
6056769 | Epstein et al. | May 2000 | A |
6063061 | Wallace | May 2000 | A |
6083522 | Chu | Jul 2000 | A |
6090130 | Nash et al. | Jul 2000 | A |
6117145 | Wood | Sep 2000 | A |
6152943 | Sawhney | Nov 2000 | A |
6162240 | Cates et al. | Dec 2000 | A |
6162241 | Coury et al. | Dec 2000 | A |
6165201 | Sawhney | Dec 2000 | A |
6179862 | Sawhney | Jan 2001 | B1 |
6223936 | Jeanbourquin | May 2001 | B1 |
6238412 | Dubrul et al. | May 2001 | B1 |
6270484 | Yoon | Aug 2001 | B1 |
6271278 | Park | Aug 2001 | B1 |
6287323 | Hammerslag | Sep 2001 | B1 |
6296658 | Gershony | Oct 2001 | B1 |
6299597 | Buscemi et al. | Oct 2001 | B1 |
6302898 | Edwards et al. | Oct 2001 | B1 |
6325789 | Janzen | Dec 2001 | B1 |
6350274 | Li | Feb 2002 | B1 |
6368300 | Fallon et al. | Apr 2002 | B1 |
6371975 | Cruise et al. | Apr 2002 | B2 |
6379373 | Sawhney | Apr 2002 | B1 |
6458147 | Cruise et al. | Oct 2002 | B1 |
6464712 | Epstein et al. | Oct 2002 | B1 |
6475177 | Suzuki | Nov 2002 | B1 |
6514534 | Sawhney | Feb 2003 | B1 |
6527734 | Cragg et al. | Mar 2003 | B2 |
6540735 | Ashby et al. | Apr 2003 | B1 |
6562059 | Edwards et al. | May 2003 | B2 |
6566406 | Pathak | May 2003 | B1 |
6569185 | Ungs | May 2003 | B2 |
6605294 | Sawhney | Aug 2003 | B2 |
6608117 | Gvozdic | Aug 2003 | B1 |
6610026 | Cragg | Aug 2003 | B2 |
6613070 | Redmond et al. | Sep 2003 | B2 |
6626861 | Hart | Sep 2003 | B1 |
6626918 | Ginn | Sep 2003 | B1 |
6635068 | Dubrul et al. | Oct 2003 | B1 |
6689148 | Sawhney | Feb 2004 | B2 |
6699261 | Cates et al. | Mar 2004 | B1 |
6703047 | Sawhney | Mar 2004 | B2 |
6774151 | Malmgren | Aug 2004 | B2 |
6818008 | Cates et al. | Nov 2004 | B1 |
6818018 | Sawhney | Nov 2004 | B1 |
6863924 | Ranganathan | Mar 2005 | B2 |
6887974 | Pathak | May 2005 | B2 |
6890342 | Zhu et al. | May 2005 | B2 |
6890343 | Ginn et al. | May 2005 | B2 |
6899727 | Armstrong et al. | May 2005 | B2 |
6960617 | Omidian | Nov 2005 | B2 |
6994686 | Cruise et al. | Feb 2006 | B2 |
7009034 | Pathak | Mar 2006 | B2 |
7331979 | Khosravi | Feb 2008 | B2 |
7335220 | Khosravi | Feb 2008 | B2 |
7611479 | Cragg et al. | Nov 2009 | B2 |
7621936 | Cragg et al. | Nov 2009 | B2 |
7790192 | Sawhney et al. | Sep 2010 | B2 |
7806856 | Bagaoisan | Oct 2010 | B2 |
7806903 | Shibata et al. | Oct 2010 | B2 |
7850710 | Huss | Dec 2010 | B2 |
7955353 | Ashby et al. | Jun 2011 | B1 |
7993367 | Bagaoisan et al. | Aug 2011 | B2 |
8029533 | Bagaoisan et al. | Oct 2011 | B2 |
8128654 | Khosravi et al. | Mar 2012 | B2 |
8382797 | Khosravi et al. | Feb 2013 | B2 |
8382798 | Khosravi et al. | Feb 2013 | B2 |
20010031948 | Cruise et al. | Oct 2001 | A1 |
20010046518 | Sawhney | Nov 2001 | A1 |
20010047187 | Milo et al. | Nov 2001 | A1 |
20010051813 | Hnojewyj | Dec 2001 | A1 |
20020015724 | Yang et al. | Feb 2002 | A1 |
20020062104 | Ashby et al. | May 2002 | A1 |
20020072767 | Zhu | Jun 2002 | A1 |
20020106409 | Sawhney et al. | Aug 2002 | A1 |
20020111392 | Cruise | Aug 2002 | A1 |
20020111651 | Ungs | Aug 2002 | A1 |
20020188319 | Morris et al. | Dec 2002 | A1 |
20020193808 | Belef | Dec 2002 | A1 |
20030008831 | Yang et al. | Jan 2003 | A1 |
20030012734 | Pathak | Jan 2003 | A1 |
20030051735 | Pavcnik et al. | Mar 2003 | A1 |
20030088269 | Ashby | May 2003 | A1 |
20030088271 | Cragg et al. | May 2003 | A1 |
20030135234 | Fisher et al. | Jul 2003 | A1 |
20030135235 | Fisher et al. | Jul 2003 | A1 |
20030135236 | Fisher et al. | Jul 2003 | A1 |
20030139770 | Fisher et al. | Jul 2003 | A1 |
20030139771 | Fisher et al. | Jul 2003 | A1 |
20030139772 | Fisher et al. | Jul 2003 | A1 |
20030139773 | Fisher et al. | Jul 2003 | A1 |
20030233120 | Akerfeldt | Dec 2003 | A1 |
20040122350 | Zhong et al. | Jun 2004 | A1 |
20040143290 | Brightbill | Jul 2004 | A1 |
20040147016 | Rowley | Jul 2004 | A1 |
20040236262 | McIntosh et al. | Nov 2004 | A1 |
20040267308 | Bagaoisan et al. | Dec 2004 | A1 |
20050085852 | Ditter | Apr 2005 | A1 |
20060015171 | Armstrong | Jan 2006 | A1 |
20060034930 | Khosravi et al. | Feb 2006 | A1 |
20060100664 | Pai et al. | May 2006 | A1 |
20060253037 | Ginn | Nov 2006 | A1 |
20060253072 | Pai | Nov 2006 | A1 |
20070060950 | Khosravi | Mar 2007 | A1 |
20070135837 | Yassinzadeh | Jun 2007 | A1 |
20070231366 | Sawhney | Oct 2007 | A1 |
20080097521 | Khosravi et al. | Apr 2008 | A1 |
20090088793 | Bagaoisan et al. | Apr 2009 | A1 |
20090254110 | Bagaoisan et al. | Oct 2009 | A1 |
20100168767 | Yassinzadeh et al. | Jul 2010 | A1 |
20100168789 | Bagaoisan et al. | Jul 2010 | A1 |
20100211000 | Killion et al. | Aug 2010 | A1 |
20100234726 | Sirimanne et al. | Sep 2010 | A1 |
20120089177 | Tegels | Apr 2012 | A1 |
Number | Date | Country |
---|---|---|
0476178 | Mar 1992 | EP |
0482350 | Apr 1992 | EP |
0716833 | Jun 1996 | EP |
9222252 | Dec 1992 | WO |
9413210 | Jun 1994 | WO |
9428798 | Dec 1994 | WO |
9922646 | May 1999 | WO |
0014155 | Mar 2000 | WO |
0019912 | Apr 2000 | WO |
03009764 | Feb 2003 | WO |
03087254 | Oct 2003 | WO |
03004749 | Nov 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20120290001 A1 | Nov 2012 | US |